Literature DB >> 11348617

Usefulness of the myocardial performance index for early detection of anthracycline-induced cardiotoxicity in children.

B W Eidem1, B G Sapp, C R Suarez, F Cetta.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11348617     DOI： 10.1016/s0002-9149(01)01476-x

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


× No keyword cloud information.
  24 in total

1.  Expert consensus for multimodality imaging evaluation of adult patients during and after cancer therapy: a report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging.

Authors:  Juan Carlos Plana; Maurizio Galderisi; Ana Barac; Michael S Ewer; Bonnie Ky; Marielle Scherrer-Crosbie; Javier Ganame; Igal A Sebag; Deborah A Agler; Luigi P Badano; Jose Banchs; Daniela Cardinale; Joseph Carver; Manuel Cerqueira; Jeanne M DeCara; Thor Edvardsen; Scott D Flamm; Thomas Force; Brian P Griffin; Guy Jerusalem; Jennifer E Liu; Andreia Magalhães; Thomas Marwick; Liza Y Sanchez; Rosa Sicari; Hector R Villarraga; Patrizio Lancellotti
Journal:  Eur Heart J Cardiovasc Imaging       Date:  2014-10       Impact factor: 6.875

2.  The effects of pre-pregnancy obesity on fetal cardiac functions.

Authors:  Ibrahim Ece; Abdurrahman Uner; Sevket Balli; Ayse Esin Kibar; Mehmet Burhan Oflaz; Mertihan Kurdoglu
Journal:  Pediatr Cardiol       Date:  2014-01-18       Impact factor: 1.655

3.  Feasibility and Reproducibility of Echocardiographic Measures in Children with Muscular Dystrophies.

Authors:  Christopher F Spurney; Francis M McCaffrey; Avital Cnaan; Lauren P Morgenroth; Sunil J Ghelani; Heather Gordish-Dressman; Adrienne Arrieta; Anne M Connolly; Timothy E Lotze; Craig M McDonald; Robert T Leshner; Paula R Clemens
Journal:  J Am Soc Echocardiogr       Date:  2015-04-21       Impact factor: 5.251

Review 4.  Late Cardiotoxicity: Issues for Childhood Cancer Survivors.

Authors:  Jyothsna Akam-Venkata; Vivian I Franco; Steven E Lipshultz
Journal:  Curr Treat Options Cardiovasc Med       Date:  2016-07

5.  Assessment of early-onset chronic progressive anthracycline cardiotoxicity in children: different response patterns of right and left ventricles.

Authors:  Abdullah Kocabaş; Fırat Kardelen; Halil Ertuğ; Bilge Aldemir-Kocabaş; Özgür Tosun; Akif Yeşilipek; Volkan Hazar; Gayaz Akçurin
Journal:  Pediatr Cardiol       Date:  2013-07-03       Impact factor: 1.655

Review 6.  Managing chemotherapy-related cardiotoxicity in survivors of childhood cancers.

Authors:  Steven E Lipshultz; Melissa B Diamond; Vivian I Franco; Sanjeev Aggarwal; Kasey Leger; Maria Verônica Santos; Stephen E Sallan; Eric J Chow
Journal:  Paediatr Drugs       Date:  2014-10       Impact factor: 3.022

Review 7.  Chemotherapy and cardiotoxicity.

Authors:  Howard Broder; Roberta A Gottlieb; Norman E Lepor
Journal:  Rev Cardiovasc Med       Date:  2008       Impact factor: 2.930

8.  Tissue and flow myocardial performance index measurements taken during dobutamine stress echocardiography for early diagnosis of late anthracycline cardiotoxicity.

Authors:  Ayşe Yildirim; F Sedef Tunaoğlu; F Güçlü Pinarli; Mustafa Ilhan; Aynur Oğuz; Ceyda Karadeniz; Rana Olguntürk; Deniz Oğuz; Serdar Kula
Journal:  Pediatr Cardiol       Date:  2009-11-24       Impact factor: 1.655

9.  Cardiac functional evaluation using vector velocity imaging after chemotherapy including anthracyclines in children with cancer.

Authors:  Jong Hun Park; Yeo Hyang Kim; Myung Chul Hyun; Heung Sik Kim
Journal:  Korean Circ J       Date:  2009-09-30       Impact factor: 3.243

10.  Myocardial performance index and biochemical markers for early detection of doxorubicin-induced cardiotoxicity in children with acute lymphoblastic leukaemia.

Authors:  Antonio Ruggiero; Gabriella De Rosa; Daniela Rizzo; Andrea Leo; Palma Maurizi; Alessia De Nisco; Francesca Vendittelli; Cecilia Zuppi; Alvaro Mordente; Riccardo Riccardi
Journal:  Int J Clin Oncol       Date:  2012-08-22       Impact factor: 3.402
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.